FindTrial
Sign In

A study to compare two medicines to decrease pain after surgery.

Comparative study of epidural Bupivacaine with Dexmedetomidine vs Bupivacaine with Fentanyl on intraoperative hemodynamics and postoperative pain relief in gynaecological oncology surgeries. - .

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/059123
Enrollment
80
Registered
2023-10-26
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Epidural dexmeditomidine vs fentanyl: To assess the pain score in both the drug groups Control Intervention1: 40 patients given 0.08 % Bupivacaine given epidurally via epidural infusion

Sponsors

SRI RAMAKRISHNA HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade 1 and 2 patients. Patients with age group of 18 to 65years. • Patients undergoing elective gynaecology oncology surgeries. Patients who provide consent for surgery.

Exclusion criteria

Exclusion criteria: Patient refusal. ASA >3 Patients allergic to study drug. Patients with significant coagulopathy. Patients with absolute contraindication for regional anaesthesia.

Design outcomes

Primary

MeasureTime frame
To assess the time for first rescue analgesic requirement in patients receiving epidural bupivacaine with dexmedetomidine vs epidural bupivacaine with fentanyl in gynaecological oncology surgeries.Timepoint: Six months—

Secondary

MeasureTime frame
To assess the incidence of hypotension, bradycardia, pruritus in patients receiving epidural bupivacaine with dexmedetomidine vs epidural bupivacaine with fentanyl in gynaecological oncology surgeries.Timepoint: Six months—

Countries

India

Contacts

Public ContactDr.SMonisha

SRI RAMAKRISHNA HOSPITAL

arjunanramya@gmail.com9566526296

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026